GUIDED THERAPEUTICS INC
Close on Oct 19, 2026
- Market cap
- $15.45M
- P/E (TTM)
- –
- Dividend yield
- –
About Guided Therapeutics
Electromedical & Electrotherapeutic Apparatus, SIC 3845
Guided Therapeutics, Inc. is a medical technology company focused on developing and commercializing medical devices for cancer detection. Its primary product is the LuViva Advanced Cervical Scan, a non-invasive, biophotonic point-of-care device designed to identify cervical cancers and precancers using light scanning, alongside single-use disposable calibration and alignment cervical guides. The company's technology serves two main applications: primary cervical cancer screening in developing regions and triage following abnormal Pap or HPV tests in developed markets. LuViva targets healthcare programs, foreign governments, non-governmental organizations, and clinical OB-GYN practices.
Operating primarily through regional and country-specific distributors, the company has executed formal distribution agreements covering over 40 countries, with active partnerships in regions including China, Southeast Asia, Central and Eastern Europe, and Russia. Through late 2025, it has distributed 158 LuViva devices and approximately 78,950 disposable cervical guides worldwide. Guided Therapeutics maintains three regular employees and is headquartered in Peachtree Corners, Georgia.
Summary of the business section of Guided Therapeutics's latest annual report, written by StockData.
Company profile
Company
- Legal name
- GUIDED THERAPEUTICS INC
- Founded
- 1992
- Headquarters
- Peachtree Corners, GA
- Address
- 5835 Peachtree Corners East, Suite B 30092
- Phone
- (770) 242-8723
- Website
- guidedinc.com
- Employees
- 3, Dec 31, 2025
- Industry
- Electromedical & Electrotherapeutic Apparatus
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
- Auditor
- UHY LLP, Sterling Heights, Michigan
Stock & identifiers
- Ticker
- GTHP
- Exchange
- OTC
- IPO date
- Jul 2, 1997
- Shares outstanding
- 97M, Aug 7, 2026
- Public float
- $10.52M, Jun 30, 2025
- Filer category
- Non-accelerated filer<br>Smaller reporting company
- Stock splits
- 1-for-797 reverse, Nov 14, 2018; 1-for-812 reverse, Dec 5, 2016
- SEC CIK
- 924515
- EIN
- 58-2029543
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Richard P. Blumberg | Director | 13,543,130 |
| Michael C. James | Director | 1,001,863 |
| John E. Imhoff | Director | 21,252,673 |
| Alan Grujic | Director | 1,817,541 |
Employees
Headcount reported in annual reports
“As of December 31, 2025, we had three regular employees and five consultants to provide services to us on a full- or part-time basis.”
Corporate history
Events identified from SEC filings